Share-based Payment Arrangement, Expense in USD of CASSAVA SCIENCES INC from Q2 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
CASSAVA SCIENCES INC quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q2 2011 to Q3 2025.
  • CASSAVA SCIENCES INC Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $4.4M, a 21.5% decline year-over-year.
  • CASSAVA SCIENCES INC Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $20M, a 57.4% increase year-over-year.
  • CASSAVA SCIENCES INC annual Share-based Payment Arrangement, Expense for 2024 was $16.3M, a 255% increase from 2023.
  • CASSAVA SCIENCES INC annual Share-based Payment Arrangement, Expense for 2023 was $4.59M, a 122% increase from 2022.
  • CASSAVA SCIENCES INC annual Share-based Payment Arrangement, Expense for 2022 was $2.07M, a 17.5% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

CASSAVA SCIENCES INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $20M $4.4M -$1.21M -21.5% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $21.2M $4.58M +$1.98M +76% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $19.2M $5.23M +$2.89M +124% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $16.3M $5.74M +$3.61M +170% 01 Oct 2024 31 Dec 2024 10-K 03 Mar 2025
Q3 2024 $12.7M $5.61M +$4.66M +491% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 $8.02M $2.6M +$1.77M +212% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 $6.25M $2.34M +$1.66M +247% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 $4.59M $2.13M +$1.51M +245% 01 Oct 2023 31 Dec 2023 10-K 03 Mar 2025
Q3 2023 $3.07M $949K +$480K +102% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 $2.59M $835K +$350K +72.2% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 $2.24M $673K +$178K +36% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024
Q4 2022 $2.07M $617K +$95K +18.2% 01 Oct 2022 31 Dec 2022 10-K 03 Mar 2025
Q3 2022 $1.97M $469K -$103K -18% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 $2.07M $485K +$70K +16.9% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023
Q1 2022 $2M $495K +$245K +98% 01 Jan 2022 31 Mar 2022 10-Q 01 May 2023
Q4 2021 $1.76M $522K +$284K +119% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2024
Q3 2021 $1.48M $572K +$344K +151% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 $1.13M $415K +$163K +64.7% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 $968K $250K -$20K -7.41% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q4 2020 $988K $238K -$66K -21.7% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023
Q3 2020 $1.05M $228K -$91K -28.5% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 $1.15M $252K -$77K -23.4% 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021
Q1 2020 $1.22M $270K -$74K -21.5% 01 Jan 2020 31 Mar 2020 10-Q 29 Apr 2021
Q4 2019 $1.3M $304K -$100K -24.8% 01 Oct 2019 31 Dec 2019 10-K 23 Mar 2021
Q3 2019 $1.4M $319K -$165K -34.1% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 $1.56M $329K -$369K -52.9% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020
Q1 2019 $1.93M $344K -$458K -57.1% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020
Q4 2018 $2.39M $404K 01 Oct 2018 31 Dec 2018 10-K 26 Mar 2020
Q3 2018 $484K -$204K -29.7% 01 Jul 2018 30 Sep 2018 10-Q 29 Oct 2019
Q2 2018 $698K -$11K -1.55% 01 Apr 2018 30 Jun 2018 10-Q 12 Aug 2019
Q1 2018 $802K -$25K -3.02% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019
Q3 2017 $688K -$157K -18.6% 01 Jul 2017 30 Sep 2017 10-Q 30 Oct 2018
Q2 2017 $709K -$225K -24.1% 01 Apr 2017 30 Jun 2017 10-Q 26 Jul 2018
Q1 2017 $827K -$883K -51.6% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018
Q3 2016 $845K +$50K +6.29% 01 Jul 2016 30 Sep 2016 10-Q 01 Nov 2017
Q2 2016 $934K +$53K +6.02% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017
Q1 2016 $1.71M +$748K +77.8% 01 Jan 2016 31 Mar 2016 10-Q 26 Apr 2017
Q3 2015 $795K -$295K -27.1% 01 Jul 2015 30 Sep 2015 10-Q 26 Oct 2016
Q2 2015 $881K -$3K -0.34% 01 Apr 2015 30 Jun 2015 10-Q 19 Jul 2016
Q1 2015 $962K +$179K +22.9% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016
Q3 2014 $1.09M +$251K +29.9% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2014
Q2 2014 $884K +$72K +8.87% 01 Apr 2014 30 Jun 2014 10-Q 06 Aug 2014
Q1 2014 $783K +$104K +15.3% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2014
Q3 2013 $839K -$1.42M -62.8% 01 Jul 2013 30 Sep 2013 10-Q 05 Nov 2014
Q2 2013 $812K -$57K -6.56% 01 Apr 2013 30 Jun 2013 10-Q 06 Aug 2014
Q1 2013 $679K -$228K -25.1% 01 Jan 2013 31 Mar 2013 10-Q 07 May 2014
Q3 2012 $2.26M +$764K +51.2% 01 Jul 2012 30 Sep 2012 10-Q 01 Nov 2013
Q2 2012 $869K -$554K -38.9% 01 Apr 2012 30 Jun 2012 10-Q 01 Aug 2013
Q1 2012 $907K 01 Jan 2012 31 Mar 2012 10-Q 24 Apr 2013
Q3 2011 $1.49M 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012
Q2 2011 $1.42M 01 Apr 2011 30 Jun 2011 10-Q 02 Aug 2012

CASSAVA SCIENCES INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $16.3M +$11.7M +255% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2025
2023 $4.59M +$2.52M +122% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025
2022 $2.07M +$307K +17.5% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025
2021 $1.76M +$771K +78% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024
2020 $988K -$308K -23.8% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023
2019 $1.3M -$1.09M -45.7% 01 Jan 2019 31 Dec 2019 10-K 23 Mar 2021
2018 $2.39M 01 Jan 2018 31 Dec 2018 10-K 26 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.